Related Experiment Video
Updated: Nov 28, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
The Network of Inflammatory Mechanisms in Lupus Nephritis
1Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan.
Abstract:
Several signaling pathways are involved in the progression of kidney disease in humans and in animal models, and kidney disease is usually due to the sustained activation of these pathways. Some of the best understood pathways are specific proinflammatory cytokine and protein kinase pathways (e.g., protein kinase C and mitogen-activated kinase pathways, which cause cell proliferation and fibrosis and are associated with angiotensin II) and transforming growth factor-beta (TGF-β) signaling pathways (e.g., the TGF-β signaling pathway, which leads to increased fibrosis and kidney scarring. It is thus necessary to continue to advance our knowledge of the pathogenesis and molecular biology of kidney disease and to develop new treatments. This review provides an update of important findings about kidney diseases (including diabetic nephropathy, lupus nephritis, and vasculitis, i.e., vasculitis with antineutrophilic cytoplasmic antibodies). New disease targets, potential pathological pathways, and promising therapeutic approaches from basic science to clinical practice are presented, and the blocking of JAK/STAT and TIM-1/TIM-4 signaling pathways as potential novel therapeutic agents in lupus nephritis is discussed.
Insights
Kidney disease progression involves sustained signaling pathway activation, leading to cell proliferation and fibrosis. Targeting pathways like JAK/STAT and TIM-1/TIM-4 offers new therapeutic potential for conditions such as lupus nephritis.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Kidney disease pathogenesis is linked to sustained activation of specific signaling pathways.
- Proinflammatory cytokine, protein kinase (e.g., PKC, MAPK), and TGF-β pathways contribute to cell proliferation, fibrosis, and scarring in kidney disease.
- Understanding molecular mechanisms is crucial for developing effective treatments for kidney diseases like diabetic nephropathy, lupus nephritis, and vasculitis.
Purpose of the Study:
- To review recent advancements in understanding kidney disease pathogenesis and molecular biology.
- To highlight novel disease targets, pathological pathways, and therapeutic strategies.
- To discuss the potential of blocking JAK/STAT and TIM-1/TIM-4 signaling pathways in lupus nephritis treatment.
Main Methods:
- Literature review of current findings on kidney disease.
- Analysis of signaling pathways implicated in kidney disease progression.
- Evaluation of emerging therapeutic approaches from basic science to clinical application.
Main Results:
- Sustained activation of signaling pathways drives kidney disease progression, causing fibrosis and scarring.
- Specific pathways like TGF-β are key contributors to kidney pathology.
- JAK/STAT and TIM-1/TIM-4 signaling pathways are identified as potential novel therapeutic targets, particularly for lupus nephritis.
Conclusions:
- Continued research into kidney disease molecular biology is essential for therapeutic innovation.
- Targeting specific signaling pathways presents promising avenues for treating various kidney diseases.
- Blocking JAK/STAT and TIM-1/TIM-4 pathways shows potential as a novel therapeutic strategy for lupus nephritis.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Nephrotic Syndrome I : Introduction
Inflammatory Response I: Vascular and Cellular
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammation

